Successful DAA therapy for chronic hepatitis C reduces HLA-DR on monocytes and circulating immune mediators: A long-term follow-up study

Immunology Letters(2020)

引用 0|浏览11
暂无评分
摘要
•Long-term sustained reduction in immune mediators occurs after HCV eradication.•Greater immune modulation occurs in experimented patients after DAA therapy.•Monocyte activation status is reduced in one year after the end of DAA therapy.•Liver stiffness improvement occurs after successful DAA therapy.•Successful DAA treatment enables a scenario of inflammatory status restoration.
更多
查看译文
关键词
1y,DCV,RBV,SD,SMV,SOF,SVR
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要